Filed: 8/14/2026ACC: 0001636587-26-000067
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $366.46M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$366.46M
Total AUM (reported)
29.07M
Total Shares
Allocation by class
COM$294.04M80.2%
COM NEW$21.93M6.0%
COMMON STOCK$20.66M5.6%
COM STK$16.87M4.6%
CLASS A COM$12.95M3.5%
Portfolio Concentration
Top 3$181.98M49.7%
4–10$148.52M40.5%
11–25$35.96M9.8%
Top 3 weight
49.7%
Top 10 weight
90.2%
Voting Authority Distribution
Total shares with voting rights: 29.07M
Sole
Full voting authority
29.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$80.39M
21.94%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.67M
TypeSH
Market value$61.58M
16.80%
Sole
1.67M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.14M
TypeSH
Market value$40.00M
10.92%
Sole
2.14M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares3.50M
TypeSH
Market value$36.03M
9.83%
Sole
3.50M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares4.13M
TypeSH
Market value$33.50M
9.14%
Sole
4.13M
Shared
0.00
None
0.00
JADE BIOSCEINCES INC
SOLEShares986.76K
TypeSH
Market value$21.93M
5.98%
Sole
986.76K
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$19.10M
5.21%
Sole
643.38K
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares1.52M
TypeSH
Market value$14.83M
4.05%
Sole
1.52M
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares2.84M
TypeSH
Market value$12.95M
3.53%
Sole
2.84M
Shared
0.00
None
0.00
HELUS PHARMA INC.
SOLEShares1.54M
TypeSH
Market value$10.18M
2.78%
Sole
1.54M
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$6.69M
1.83%
Sole
1.75M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares929.08K
TypeSH
Market value$6.60M
1.80%
Sole
929.08K
Shared
0.00
None
0.00
LEONABIO, INC.
SOLEShares634.54K
TypeSH
Market value$5.83M
1.59%
Sole
634.54K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares1.47M
TypeSH
Market value$5.61M
1.53%
Sole
1.47M
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$5.22M
1.42%
Sole
1.14M
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares216.17K
TypeSH
Market value$2.75M
0.75%
Sole
216.17K
Shared
0.00
None
0.00
EUGENE THERAPEUTICS
SOLEShares1.27M
TypeSH
Market value$2.20M
0.60%
Sole
1.27M
Shared
0.00
None
0.00
JASPER THERAPEUTICS
SOLEShares1.44M
TypeSH
Market value$604.0K
0.16%
Sole
1.44M
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares108.13K
TypeSH
Market value$447.6K
0.12%
Sole
108.13K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares1.43K
TypeSH
Market value$926.00
<0.01%
Sole
1.43K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $80.39M 21.94% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.67M | SH | $61.58M 16.80% | 1.67M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.14M | SH | $40.00M 10.92% | 2.14M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 3.50M | SH | $36.03M 9.83% | 3.50M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 4.13M | SH | $33.50M 9.14% | 4.13M | 0.00 | 0.00 |
JADE BIOSCEINCES INCSOLE | COM NEW | 986.76K | SH | $21.93M 5.98% | 986.76K | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $19.10M 5.21% | 643.38K | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | COMMON STOCK | 1.52M | SH | $14.83M 4.05% | 1.52M | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 2.84M | SH | $12.95M 3.53% | 2.84M | 0.00 | 0.00 |
HELUS PHARMA INC.SOLE | COM STK | 1.54M | SH | $10.18M 2.78% | 1.54M | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.75M | SH | $6.69M 1.83% | 1.75M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 929.08K | SH | $6.60M 1.80% | 929.08K | 0.00 | 0.00 |
LEONABIO, INC.SOLE | COMMON STOCK | 634.54K | SH | $5.83M 1.59% | 634.54K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM | 1.47M | SH | $5.61M 1.53% | 1.47M | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 1.14M | SH | $5.22M 1.42% | 1.14M | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 216.17K | SH | $2.75M 0.75% | 216.17K | 0.00 | 0.00 |
EUGENE THERAPEUTICSSOLE | COM | 1.27M | SH | $2.20M 0.60% | 1.27M | 0.00 | 0.00 |
JASPER THERAPEUTICSSOLE | COM | 1.44M | SH | $604.0K 0.16% | 1.44M | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 108.13K | SH | $447.6K 0.12% | 108.13K | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 1.43K | SH | $926.00 <0.01% | 1.43K | 0.00 | 0.00 |